Belvedere Trading
ANVS icon

Belvedere Trading’s Annovis Bio ANVS Stock Holding History

Belvedere Trading’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,500
Closed -$25.9K – 717
2024
Q2 		$25.9K Sell
4,500
-38,800
-90% -$314K ﹤0.01% 553
2024
Q1 		$515K Buy
43,300
+17,300
+67% +$189K ﹤0.01% 153
2023
Q4 		$486K Buy
+26,000
New +$231K ﹤0.01% 166

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Belvedere Trading's ANVS Position: Q3 2024 in Review

Belvedere Trading sold out of Annovis Bio (ANVS) in Q3 2024, closing a stake of 4,778 shares — an estimated $27.5K sold.

Belvedere Trading first reported a position in ANVS in Q2 2024 and held it in 1 quarter. The position peaked at $27.5K in Q2 2024. 35 funds tracked by Wall St. Rank hold ANVS as of Q3 2024.

  • Belvedere Trading reported no remaining Annovis Bio position as of Q3 2024 after selling out during the quarter.
  • Belvedere Trading sold 4,778 Annovis Bio shares in Q3 2024, an estimated $27.5K.
  • Belvedere Trading first reported a position in Annovis Bio in Q2 2024 and held it in 1 quarter.
  • Belvedere Trading's Annovis Bio position peaked at $27.5K in Q2 2024.
  • 35 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2024.

Based on Belvedere Trading's 13F filing for Q3 2024, filed 30 Oct 2024.